<![CDATA[Hansa Biopharma — Juni 2025]]>Hansa Biopharma rejser kapital via emission og konvertergæld for at sikre finansiering af sine to store fase III‑studier i 2025–26 og omlægge gælden med NovaQuest, samtidig med at udvande eksisterende aktieejere med ca. 20 % https://www.hansabiopharma.com/media/press-releases/2025/hansa-biopharma-has-carried-out-a-directed-cash-share-issue-of-approx-msek-232-and-entered-into-binding-agreement-to-restructure-debt-held-by-novaquest-including-set-off-issue-of-usd-14-9-million/

]]>https://dev.proinvestor.com/forum/topic/400763/hansa-biopharma-juni-2025RSS for NodeSat, 06 Jun 2026 05:04:31 GMTThu, 19 Jun 2025 10:19:08 GMT60<![CDATA[Reply to Hansa Biopharma — Juni 2025 on Mon, 30 Jun 2025 05:11:10 GMT]]>Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London https://www.hansabiopharma.com/media/press-releases/2025/hansa-biopharma-presents-positive-outcomes-of-five-year-follow-up-study-of-imlifidase-in-kidney-transplantation-at-esot-congress-2025-in-london/

]]>https://dev.proinvestor.com/forum/post/8007846https://dev.proinvestor.com/forum/post/8007846Mon, 30 Jun 2025 05:11:10 GMT<![CDATA[Reply to Hansa Biopharma — Juni 2025 on Mon, 30 Jun 2025 04:37:27 GMT]]>"Far from its previous peaks, the biotech sector is now trading at the same levels it reached back in 2015.

That’s a full decade of underperformance, an anomaly in a market driven by innovation, disruption, and long-term growth". Læs mere i denne tråd fra X: https://x.com/nataninvesting/status/1938931955422113924

]]>https://dev.proinvestor.com/forum/post/8007845https://dev.proinvestor.com/forum/post/8007845Mon, 30 Jun 2025 04:37:27 GMT